Document is current
Any future updates will be listed below
-
Authors
Pérez-Montero, Héctor https://orcid.org/0000-0002-9756-5088
Lozano, Alicia https://orcid.org/0000-0003-0528-5212
de Blas, Rodolfo https://orcid.org/0000-0002-0390-4334
Sánchez, Juan José https://orcid.org/0000-0003-0677-3680
Martínez, Evelyn https://orcid.org/0000-0002-3463-5333
Laplana, María https://orcid.org/0000-0001-9826-9494
Gil-Gil, Miguel https://orcid.org/0000-0003-1380-2718
Garcia-Tejedor, Amparo https://orcid.org/0000-0003-3398-0570
Pernas, Sonia https://orcid.org/0000-0002-1485-5080
Falo, Catalina https://orcid.org/0000-0002-5714-6823
Godino, Óscar https://orcid.org/0000-0002-1004-6366
Pla, Maria J. https://orcid.org/0000-0001-7119-4031
Guedea, Ferrán https://orcid.org/0000-0001-8798-8696
Navarro-Martin, Arturo https://orcid.org/0000-0002-1327-5367
- License Information
-
More Information
Article History
Received: 1 December 2022
Accepted: 3 January 2023
First Online: 16 January 2023
Declarations
:
: Miguel Gil-Gil has received personal fees from Pfizer, Daiichi Sankyo, Novartis, Gilead, AstraZeneca, and Roche. These fees are not related to this study. The rest of the authors have no relevant financial or non-financial interests to disclose. The authors alone are responsible for the content and writing of the paper.
: All procedures were performed under the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval for this study was granted by the Ethics Committee of Hospital Universitari de Bellvitge (15.06.2021/PR224/21).
: For this type of study, formal consent is not required. The patients did not receive any specific informed consent as data were collected from a retrospective review of electronic medical records. The patients signed the informed consent for the usual procedure.
